Gain Therapeutics Inc Stock
Gain Therapeutics Inc Stock price
Key metrics
| Market capitalization | $36.52m |
| Enterprise Value | $20.39m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 3.05 |
| Revenue growth (TTM) Revenue growth | -100.00% |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-21.85m |
| Free Cash Flow (TTM) Free Cash Flow | $-18.99m |
Is Gain Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.
Gain Therapeutics Inc Stock Analysis
Analyst Opinions
5 Analysts have issued a Gain Therapeutics Inc forecast:
Analyst Opinions
5 Analysts have issued a Gain Therapeutics Inc forecast:
Financial data from Gain Therapeutics Inc
| Jun '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -0.09 -0.09 |
350%
350%
|
|
| EBITDA | -22 -22 |
2%
2%
|
EBIT (Operating Income) EBIT | -22 -22 |
2%
2%
|
| Net Profit | -22 -22 |
2%
2%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Gain Therapeutics Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Gain Therapeutics Inc Stock News
Company Profile
Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never before targeted. Its See-Tx target identification platform uses the published 3D structure of enzymes and a proprietary computational technology to discover new allosteric binding sites and predict their druggability. The firm is also unlocking new treatment options to treat disorders characterized by protein misfolding. The company was founded by Khalid Islam in 2017 and is headquartered in Bethesda, MD.
| Head office | United States |
| CEO | Gene Mack |
| Employees | 32 |
| Founded | 2017 |
| Website | www.gaintherapeutics.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
